![]() Canine Atopic Dermatitis Market Report by Drug Class Type (Glucocorticoids, Immunosuppressants, Monoclonal Antibody, and Others), Route of Administration (Topical, Oral, Injectable), Distribution Channel (Veterinary Hospitals, Pet Clinics, Pharmacies and Drugstores, and Others), and Region 2025-2033
The global canine atopic dermatitis market size reached USD 2.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of... もっと見る
英語原文をAIを使って翻訳しています。
SummaryThe global canine atopic dermatitis market size reached USD 2.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 13.1% during 2025-2033.Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs. Canine Atopic Dermatitis Market Trends: The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on drug class type, route of administration and distribution channel. Breakup by Drug Class Type: ? Glucocorticoids ? Immunosuppressants ? Monoclonal Antibody ? Others Breakup by Route of Administration: ? Topical ? Oral ? Injectable Breakup by Distribution Channel: ? Veterinary Hospitals ? Pet Clinics ? Pharmacies and Drugstores ? Others Breakup by Region: ? North America o United States o Canada ? Asia-Pacific o China o Japan o India o South Korea o Australia o Indonesia o Others ? Europe o Germany o France o United Kingdom o Italy o Spain o Russia o Others ? Latin America o Brazil o Mexico o Others ? Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc. Key Questions Answered in This Report: ? How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years? ? What has been the impact of COVID-19 on the global canine atopic dermatitis market? ? What are the key regional markets? ? What is the breakup of the market based on the drug class type? ? What is the breakup of the market based on the route of administration? ? What is the breakup of the market based on the distribution channel? ? What are the various stages in the value chain of the industry? ? What are the key driving factors and challenges in the industry? ? What is the structure of the global canine atopic dermatitis market and who are the key players? ? What is the degree of competition in the industry? Table of Contents?1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Canine Atopic Dermatitis Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Drug Class Type 6.1 Glucocorticoids 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Immunosuppressants 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Monoclonal Antibody 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Route of Administration 7.1 Topical 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Oral 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Injectable 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Distribution Channel 8.1 Veterinary Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Pet Clinics 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Pharmacies and Drugstores 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 AB Science 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.2 Bimeda Inc. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bioceltix SA 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Boehringer Ingelheim International GmbH 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.5 Ceva Sant? Animale 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Dechra Pharmaceuticals PLC 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.7 Elanco Animal Health Incorporated 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.8 Phibro Animal Health Corporation 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Toray Industries Inc. 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Vetoquinol S.A. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 Virbac 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.11.4 SWOT Analysis 14.3.12 Zoetis Inc. 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials 14.3.12.4 SWOT Analysis List of Tables/GraphsList of FiguresFigure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion USD), 2019-2024 Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion USD), 2025-2033 Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2024 Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2024 Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2024 Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2024 Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million USD), 2019 & 2024 Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024 Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million USD), 2019 & 2024 Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million USD), 2019 & 2024 Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million USD), 2019 & 2024 Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million USD), 2019 & 2024 Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million USD), 2019 & 2024 Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024 Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million USD), 2019 & 2024 Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million USD), 2019 & 2024 Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024 Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024 Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2024 Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2024 and 2033 Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million USD), 2025-2033 Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033 Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033 Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million USD), 2025-2033 Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure Table 7: Global: Canine Atopic Dermatitis Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IMARC Services Private Limited.社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD(canine)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|